Skip to content
10-Q

Quarterly Report

AV THERAPEUTICS, INC.

0001185185-14-003160

← back to feed
Filed
Nov 17, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 14, 2014 81.88M sh
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$824.03K
Operating Cash Flow restated Q3 2014 · Sep 30, 2013 −$247.38K
Cash And Equivalents Q3 2014 · Sep 30, 2014 $273.22K
Cash And Equivalents Q3 2014 · Dec 31, 2013 $576.25K
Cash And Equivalents restated Q3 2014 · Sep 30, 2013 $75.06K
Cash And Equivalents restated Q3 2014 · Dec 31, 2012 $97.44K
Stockholders Equity Q3 2014 · Sep 30, 2014 −$524.83K
Stockholders Equity Q3 2014 · Dec 31, 2013 $34.17K
Current Liabilities Q3 2014 · Sep 30, 2014 $952.02K
Current Liabilities Q3 2014 · Dec 31, 2013 $750.76K
Current Assets Q3 2014 · Sep 30, 2014 $293.97K
Current Assets Q3 2014 · Dec 31, 2013 $636.25K
Total Assets Q3 2014 · Sep 30, 2014 $427.19K
Total Assets Q3 2014 · Dec 31, 2013 $784.93K
Sga Expense Q3 2014 · Sep 30, 2014 $6.54K
Sga Expense Q3 2014 · Sep 30, 2014 $32.8K
Sga Expense restated Q3 2014 · Sep 30, 2013 $2.7K
Sga Expense restated Q3 2014 · Sep 30, 2013 $31.81K
Rd Expense Q3 2014 · Sep 30, 2014 $155.35K
Rd Expense Q3 2014 · Sep 30, 2014 $469.56K
Rd Expense Q3 2014 · Sep 30, 2013 $197.21K
Rd Expense Q3 2014 · Sep 30, 2013 $257.51K
Net Income Q3 2014 · Sep 30, 2014 −$21.7K
Net Income Q3 2014 · Sep 30, 2014 −$330.21K
Net Income restated Q3 2014 · Sep 30, 2013 −$286.36K
Net Income restated Q3 2014 · Sep 30, 2013 −$459.98K
Operating Income Q3 2014 · Sep 30, 2014 −$248.61K
Operating Income Q3 2014 · Sep 30, 2014 −$1.22M
Operating Income restated Q3 2014 · Sep 30, 2013 −$286.19K
Operating Income restated Q3 2014 · Sep 30, 2013 −$459.28K
Revenue Q3 2014 · Sep 30, 2014 $0
Revenue Q3 2014 · Sep 30, 2014 $0
Revenue Q3 2014 · Sep 30, 2013 $0
Revenue Q3 2014 · Sep 30, 2013 $0